FIRST MERCANTILE TRUST CO - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST MERCANTILE TRUST CO ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2018$345,000
+23.7%
4,771
+12.7%
0.07%
+30.9%
Q4 2017$279,000
+105.1%
4,233
+56.0%
0.06%
+120.0%
Q3 2017$136,000
-20.0%
2,714
-73.0%
0.02%
+19.0%
Q1 2016$170,000
-33.6%
10,054
-12.7%
0.02%
-19.2%
Q4 2015$256,000
+15.8%
11,522
+23.2%
0.03%
+18.2%
Q3 2015$221,000
-63.8%
9,355
+25.5%
0.02%
-57.7%
Q2 2015$610,000
+25.3%
7,455
+41.9%
0.05%
+30.0%
Q1 2015$487,0005,2550.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders